Pyxis Oncology (PYXS) Revenue & Revenue Breakdown
Pyxis Oncology Revenue Highlights
00
Pyxis Oncology Revenue by Period
Pyxis Oncology Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Pyxis Oncology generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Pyxis Oncology Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | -100.00% |
2024-03-31 | $16.15M | 372.11% |
2023-12-31 | $3.42M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Pyxis Oncology generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Pyxis Oncology Revenue Breakdown
Pyxis Oncology Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 |
---|---|---|---|
Royalty | $8.15M | $8.15M | $8.15M |
Latest
Pyxis Oncology's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Royalty (100.00%).
Pyxis Oncology Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOOK | HOOKIPA Pharma | $20.13M | $4.70M |
MREO | Mereo BioPharma Group | $10.00M | - |
ZVSA | ZyVersa Therapeutics | - | - |
OCEA | Ocean Biomedical | - | - |
CRVS | Corvus Pharmaceuticals | - | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
ZURA | Zura Bio | - | - |
PDSB | PDS Bio | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |
ELEV | Elevation Oncology | - | - |
PYXS | Pyxis Oncology | - | - |